[ Price : $8.95]
FDA approves an Idorsia NDA for Tryvio (aprocitentan) for treating hypertension in combination with other antihypertensive drugs i...[ Price : $8.95]
Federal Register notice: FDA proposes to establish criteria for the lists of drug products or drug categories that present demonst...[ Price : $8.95]
FDA approves Johnson & Johnsons Edurant PED (rilpivirine) for treating HIV-1 in combination with other antiretroviral therapies in...[ Price : $8.95]
FDA asks the Ophthalmic Devices Panel to discuss safety and other issues related to the Balance Ophthalmics FSYX ocular pump to lo...[ Price : $8.95]
FDA reports the key themes that emerged from a 3/2023 virtual meeting with patients and caregivers on long Covid.[ Price : $8.95]
CDER Office of Prescription Drug Promotion research demonstrates that consumers may be confused and conflate product benefits and ...[ Price : $8.95]
FDA solicits applications for grants to explore the role of digital health technologies in evaluating new drugs.[ Price : $8.95]
FDA proposes to evaluate drugs and categories of drugs that present demonstrable difficulties for compounding and place three cate...